Page last updated: 2024-10-22

albuterol and Besnier-Boeck Disease

albuterol has been researched along with Besnier-Boeck Disease in 1 studies

Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Krzywiecki, A1
Ziora, D1
Oklek, K1
Niepsuj, G1
Kozielski, J1
PoloĊ„ska, A1

Trials

1 trial available for albuterol and Besnier-Boeck Disease

ArticleYear
[Effect of salbutamol inhalation on small airways function in patients with sarcoidosis].
    Pneumonologia i alergologia polska, 1995, Volume: 63, Issue:5-6

    Topics: Administration, Inhalation; Adult; Albuterol; Bronchodilator Agents; Female; Forced Expiratory Volum

1995